Advanced Biomed Inc. Common Stock (ADVB) Stock Overview
Explore Advanced Biomed Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.
Advanced Biomed Inc. Common Stock (ADVB)
Key Financials
Key Financials
Market Cap
12.7M
P/E Ratio
-43.15
EPS (TTM)
$-0.11
ROE
-0.21%
ADVB Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Advanced Biomed Inc. Common Stock (NASDAQ: ADVB) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Advanced Biomed Inc. Common Stock's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ADVB on the NASDAQ shows an RSI of 54.87, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $5.87 for the NASDAQ listing.
Key metrics behind Advanced Biomed Inc. Common Stock's NASDAQ-traded stock include a P/E ratio of -43.15 and a market capitalization of 12.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ADVB on the NASDAQ.